Evaluation of Cost-Effective Therapy by Comparing Brands of the Same Formulation in Pakistan
Journal: Currents in pharmaceutical research
Year: 2024

In Pakistan, where millions face the burden of healthcare costs, the choice between branded and alternative drug formulations plays a crucial role in patient outcomes. Often, branded medications are prescribed over more cost-effective options, exacerbating financial strain for patients, especially in low- and middle-income settings. The current study is crucial to address healthcare affordability, highlighting significant cost disparities between prescribed branded medications and alternatives.